tm logo
COMBI-OGAB
Live/Registered
REGISTERED

on 28 May 2024

Last Applicant/ Owned by

Nada-ku 657-0013 Kobe-shi Hyogo 657-0013

JP

Serial Number

79372347 filed on 31st Mar 2023

Registration Number

7394363 registered on 28th May 2024

in the Principal Register

Correspondent Address

Livio RAISON SHI NAGAWA TOGOSHI 403,

TOKYO 142-0052,

JAPAN

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

COMBI-OGAB

Research and development relating to DNA synthesis technology; technical advisory services relating to DNA synthesis technology; research and development relating to production and analysis of virus vector; technological advisory services relating to production and analysis of virus vector; research and development relating to production and analysis of mRNA; technological advisory services relati Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development relating to DNA synthesis technology; technical advisory services relating to DNA synthesis technology; research and development relating to production and analysis of virus vector; technological advisory services relating to production and analysis of virus vector; research and development relating to production and analysis of mRNA; technological advisory services relating to production and analysis of mRNA; research and development relating to gene therapy; technical advisory services relating to gene therapy research; technological advisory services relating to productization of gene therapy products; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, and technical advisory services relating thereto in the fields of protein, antibody, vaccine, virus, virus vector, mRNA, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; technical advisory services relating to genome synthesis technology; research and development, and technical advisory services relating thereto in the fields of protein, vaccine, virus, virus vector, mRNA, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection, and research of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; technical advisory services relating to development of pharmaceuticals, gene therapy products, regenerative medical products, cosmetics or foodstuffs, all with genome synthesis technology; quality testing, inspection, and research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; research and development relating to production and analysis of virus vector for others; research and development relating to gene therapy products for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; quality testing, inspection, and research in the fields of agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; research and development in the field of gene expression systems; research and development in the fields of microorganisms and cells; research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; bacteriological research; biological research


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79372347

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Jun 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28th May 2024REGISTERED-PRINCIPAL REGISTER
12th Mar 2024NOTIFICATION PROCESSED BY IB
12th Mar 2024PUBLISHED FOR OPPOSITION
21st Feb 2024NOTICE OF PUBLICATION
21st Feb 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21st Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01st Feb 2024APPROVED FOR PUB - PRINCIPAL REGISTER
27th Dec 2023ASSIGNED TO EXAMINER
27th Jun 2023APPLICATION FILING RECEIPT MAILED